Furthermore, DDX10 has been shown to modulate α-synuclein toxicity in PD by sequestering and stabilising its oligomeric forms, with a depletion of DDX10 rescuing associated toxicities (Popova et al., 2021). This evidence concerns the gene DDX10 and Parkinson disease.